Legend Biotech Corporation achieved two milestones under its collaboration agreement with Janssen Biotech, Inc. for ciltacabtagene autoleucel, a B cell maturation antigen-directed CAR-T therapy.
[Legend Biotech Corporation]
6445212
nan
items
1
apa
0
default
asc
1
171809
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
